60 related articles for article (PubMed ID: 9178889)
1. N-Oct 5 is generated by in vitro proteolysis of the neural POU-domain protein N-Oct 3.
Atanasoski S; Schreiber E; Fontana A; Herr W
Oncogene; 1997 Mar; 14(11):1287-94. PubMed ID: 9178889
[TBL] [Abstract][Full Text] [Related]
2. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
3. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.
Thomson JA; Murphy K; Baker E; Sutherland GR; Parsons PG; Sturm RA; Thomson F
Oncogene; 1995 Aug; 11(4):691-700. PubMed ID: 7651733
[TBL] [Abstract][Full Text] [Related]
4. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.
Schreiber E; Merchant RE; Wiestler OD; Fontana A
Neurosurgery; 1994 Jan; 34(1):129-35. PubMed ID: 8121549
[TBL] [Abstract][Full Text] [Related]
5. Oct-1 enhances the in vitro replication of a mammalian autonomously replicating DNA sequence.
Matheos DD; Ruiz MT; Price GB; Zannis-Hadjopoulos M
J Cell Biochem; 1998 Mar; 68(3):309-27. PubMed ID: 9518258
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
7. Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (brain-2).
Schreiber E; Himmelmann A; Malipiero U; Tobler A; Stahel R; Fontana A
Cancer Res; 1992 Nov; 52(21):6121-4. PubMed ID: 1327524
[TBL] [Abstract][Full Text] [Related]
8. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development.
Jaegle M; Ghazvini M; Mandemakers W; Piirsoo M; Driegen S; Levavasseur F; Raghoenath S; Grosveld F; Meijer D
Genes Dev; 2003 Jun; 17(11):1380-91. PubMed ID: 12782656
[TBL] [Abstract][Full Text] [Related]
9. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif.
Schreiber E; Tobler A; Malipiero U; Schaffner W; Fontana A
Nucleic Acids Res; 1993 Jan; 21(2):253-8. PubMed ID: 8441633
[TBL] [Abstract][Full Text] [Related]
11. POU family transcription factors in the nervous system.
Latchman DS
J Cell Physiol; 1999 May; 179(2):126-33. PubMed ID: 10199551
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.
Nieto L; Joseph G; Stella A; Henri P; Burlet-Schiltz O; Monsarrat B; Clottes E; Erard M
J Mol Biol; 2007 Jul; 370(4):687-700. PubMed ID: 17543985
[TBL] [Abstract][Full Text] [Related]
13. [Spliced oct-1 gene mRNA isoforms with untranslated exons and a deletion in the region coding for the POU-specific domain].
Deev IE; Zhenilo SV; Polianovskiĭ OL
Mol Biol (Mosk); 2003; 37(1):139-46. PubMed ID: 12624956
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Oct-2 transcription factor in mouse mammary gland and cloning and characterization of a novel Oct-2 isoform.
Dong B; Zhao FQ
Cell Tissue Res; 2007 Jun; 328(3):595-606. PubMed ID: 17285328
[TBL] [Abstract][Full Text] [Related]
15. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
16. Characteristic patterns of N Oct-3 binding to a set of neuronal promoters.
Blaud M; Vossen C; Joseph G; Alazard R; Erard M; Nieto L
J Mol Biol; 2004 Jun; 339(5):1049-58. PubMed ID: 15178247
[TBL] [Abstract][Full Text] [Related]
17. Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage.
Smith AE; Ford KG
Nucleic Acids Res; 2005; 33(18):6011-23. PubMed ID: 16243786
[TBL] [Abstract][Full Text] [Related]
18. Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction.
Smith AG; Brightwell G; Smit SE; Parsons PG; Sturm RA
Melanoma Res; 1998 Feb; 8(1):2-10. PubMed ID: 9508370
[TBL] [Abstract][Full Text] [Related]
19. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two POU transcription factor family members from the urochordate Oikopleura dioica.
Cupit PM; Lennard ML; Hikima J; Warr GW; Cunningham C
Gene; 2006 Nov; 383():1-11. PubMed ID: 16989962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
